Cargando...
Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
Diabetes management during Ramadan fasting is challenging to the physician in terms of minimizing the risk of hypoglycemia. As compared to oral hypoglycemic agents (OHAs) and sulfonylureas (SUs), which carry a higher and significant risk of hypoglycemia, newer antidiabetic agents such as dipeptidyl...
Guardado en:
| Publicado en: | Diabetes Metab Syndr Obes |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404947/ https://ncbi.nlm.nih.gov/pubmed/25931826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S54683 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|